Gastroesophageal Reflux: all 1,086 studies

Page 3 of 11. Open to participants first (187), then studies with results posted, then the rest; newest registration first within each.

• Complications, Outcomes and Revisions Following Hiatal Hernia Repair With MIROMESHCompletedNCT03735862Results posted
• Precision Approach to PPI Therapy in Gastroesophageal Reflux DiseaseCompletedNCT03619811Not applicableResults posted
• Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)CompletedNCT03561883Phase 3Results posted
• A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)TerminatedNCT03561090Phase 3Results posted
• Fexofenadine Use in Gastroesophageal Reflux SymptomsTerminatedNCT03425097Phase 2Results posted
• Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"CompletedNCT03214952Results posted
• Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"CompletedNCT03214081Results posted
• Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory EvaluationCompletedNCT03116841Phase 4Results posted
• Correlates of GERD Symptom SeverityCompletedNCT03020550Results posted
• Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled AsthmaCompletedNCT03015610Phase 3Results posted
• GER Poses a Potential Risk for Late Complications of BPDCompletedNCT03014453Results posted
• Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)CompletedNCT02954848Phase 3Results posted
• Genotype-supported Versus Conventional Proton Pump Inhibitor DosingCompletedNCT02930824Not applicableResults posted
• Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese PatientsCompletedNCT02873689Phase 3Results posted
• Implementation of PPI Medication PGX TestingCompletedNCT02794844Phase 4Results posted
• Contrast Enhanced Ultrasound for Evaluation of Reflux NephropathyCompletedNCT02786810Phase 2Results posted
• An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of RefluxTerminatedNCT02749071Not applicableResults posted
• Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)CompletedNCT02743949Phase 2Results posted
• Impact of Head of Bed Elevation in Symptoms of Patients With Gastroesophageal Reflux DiseaseCompletedNCT02706938Not applicableResults posted
• Experimental Study to Determine the Effects of Human Refluxate on Macrophage Phenotype and Its Correlation With GERDCompletedNCT02699060Not applicableResults posted
• Role of Pepsin Assay in Wheezy InfantsCompletedNCT02685436Phase 4Results posted
• A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)CompletedNCT02637557Phase 2Results posted
• The Primary Symptoms of GERD(Gastroesophageal Reflux Disease) in Chinese Outpatients in Gastroenterology DepartmentCompletedNCT02506634Results posted
• The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux DiseaseCompletedNCT02505945Phase 4Results posted
• Neonatal Gastro-Esophageal Reflux Disease (GERD) Management TrialCompletedNCT02486263Not applicableResults posted
• Pilot Study to Image the Esophagus Using a SECM Tethered Endoscopic CapsuleCompletedNCT02445014Not applicableResults posted
• LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve GastrectomyCompletedNCT02429830Not applicableResults posted
• PREA, PK And Safety PASS Study Of IV Pantoprazole In Pediatric SubjectsTerminatedNCT02401035Phase 4Results posted
• Dietary Carbohydrate and GERD in VeteransCompletedNCT02384551Not applicableResults posted
• Dexlansoprazole in Asian Participants With Gastroesophageal Reflux DiseaseCompletedNCT02351960Phase 4Results posted
• Early Feasibility Study of the Neovasc Tiara™ Mitral Valve SystemCompletedNCT02276547Not applicableResults posted
• Using Electrical Bioimpedance Assessments to Estimate Perioperative Total Body Water and Postoperative Fluid NeedCompletedNCT02200055Not applicableResults posted
• PK Study With Pantoprazole in Obese Children and AdolescentsCompletedNCT02186652Phase 1Results posted
• A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related DiseasesCompletedNCT02153398Phase 3Results posted
• A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease PatientsCompletedNCT02135107Phase 3Results posted
• Safety Study of Airway Clearance Techniques in Infants.CompletedNCT02128867Not applicableResults posted
• Influence of IPV on GOR in Infants From 0 to 12 Months.CompletedNCT02124863Not applicableResults posted
• Nociceptors, Neurotrophic Factors and Cytokine Expression in Gastroesophageal Reflux DiseaseCompletedNCT02114216Not applicableResults posted
• Esophageal Cytology With FISH in Detecting Esophageal CancerCompletedNCT02100189Not applicableResults posted
• Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating TabletsCompletedNCT02096458Phase 1Results posted
• Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia SymptomsCompletedNCT01990339Results posted
• Treatment of IPF With Laparoscopic Anti-Reflux SurgeryCompletedNCT01982968Not applicableResults posted
• Response to Supplement and Placebo in GERDCompletedNCT01915173Not applicableResults posted
• Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERDCompletedNCT01882088Phase 4Results posted
• Gastroesophageal Reflux Treatment in SclerodermaCompletedNCT01878526Phase 3Results posted
• Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD PatientsCompletedNCT01872897Phase 3Results posted
• Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief StudyCompletedNCT01869491Phase 3Results posted
• Treatment of Extraesophageal Reflux With the Reza Band UES Assist DeviceCompletedNCT01857713Not applicableResults posted
• VenaSeal Sapheon Closure System Pivotal Study (VeClose)CompletedNCT01807585Not applicableResults posted
• Anti-reflux Control to Decrease Post Tonsillectomy PainTerminatedNCT01777854Phase 4Results posted
• Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus)CompletedNCT01669811Phase 3Results posted
• The EndoGastric Solutions TEMPO TrialCompletedNCT01647958Not applicableResults posted
• Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in AdolescentsCompletedNCT01642615Phase 2Results posted
• Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in AdolescentsCompletedNCT01642602Phase 2Results posted
• Observational Study of Anti-Reflux SurgeryCompletedNCT01624506Results posted
• Physical Activity and Gastrointestinal InvestigationsCompletedNCT01507298Results posted
• Narrow-band Imaging, Autofluorescence Imaging and Gastroesophageal Reflux DiseaseStatus unknownNCT01504971Results posted
• Phase III Study Comparing Zegerid® With Losec® for the Relief of Heartburn Associated With Gastroesophageal Reflux DiseaseCompletedNCT01493089Phase 3Results posted
• Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)CompletedNCT01472939Phase 2Results posted
• The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump InhibitorsTerminatedNCT01404832Phase 4Results posted
• To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving RabeprazoleCompletedNCT01397084Phase 4Results posted
• An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD PatientsTerminatedNCT01370863Phase 2Results posted
• Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF StudyTerminatedNCT01327963Not applicableResults posted
• The Effects of Dexlansoprazole for the Treatment of Throat-Related RefluxTerminatedNCT01317472Not applicableResults posted
• Comparative Effectiveness of Endoscopic Assessment of Gastroesophageal Reflux and Barretts EsophagusCompletedNCT01288612Not applicableResults posted
• A Randomized Trial of Medical and Surgical Treatments for Patients With GERD Symptoms That Are Refractory to Proton Pump InhibitorsCompletedNCT01265550Phase 3Results posted
• Temple Registry for the Investigation of African American Gastrointestinal Disease EpidemiologyCompletedNCT01262755Results posted
• Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male SubjectsCompletedNCT01154634Phase 2Results posted
• Study of Impact of Not Measuring Residual Gastric Volume on Nosocomial Pneumonia RatesCompletedNCT01137487Not applicableResults posted
• Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT StudyCompletedNCT01136980Not applicableResults posted
• Safety and Efficacy of Lansoprazole in Patients With Reflux DiseaseCompletedNCT01135368Phase 4Results posted
• Assessment of Zegerid on Esophageal pH in Patients With Barrett's EsophagusTerminatedNCT01129778Not applicableResults posted
• Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis PatientsCompletedNCT01119768Phase 4Results posted
• An Observational Clinical Feasibility Study of the Magnetic Esophageal SphincterCompletedNCT01058070Not applicableResults posted
• Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux DiseaseCompletedNCT01045096Phase 1Results posted
• A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May ExperienceCompletedNCT01043185Phase 2Results posted
• Tri Staple Technology Stapler Used in Gastric BypassCompletedNCT01026103Not applicableResults posted
• An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux EsophagitisCompletedNCT01008696Phase 4Results posted
• Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPICompletedNCT01005251Phase 2Results posted
• Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD)CompletedNCT00992589Phase 3Results posted
• Gastroesophageal Reflux Disease (GERD) Before and After Gastric BypassCompletedNCT00951093Results posted
• Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)CompletedNCT00911534Phase 3Results posted
• Pancreaticobiliary Reflux in Patients Without CholelithiasisCompletedNCT00890201Results posted
• Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)CompletedNCT00868296Phase 3Results posted
• Clinical Studies on Bile Acids in Barrett's EsophagusCompletedNCT00858858Not applicableResults posted
• Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor TherapyCompletedNCT00847808Phase 3Results posted
• Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux DiseaseCompletedNCT00847210Phase 1Results posted
• Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)CompletedNCT00839306Phase 3Results posted
• Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)CompletedNCT00838526Phase 3Results posted
• Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep DisordersCompletedNCT00830115Results posted
• Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux DiseaseCompletedNCT00829738Results posted
• A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric PatientsCompletedNCT00787891Phase 3Results posted
• LINX Reflux Management System Clinical Study ProtocolCompletedNCT00776997Not applicableResults posted
• Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux EsophagitisCompletedNCT00770913Phase 2/3Results posted
• Safety and Efficacy the Medigus SRS Endoscopic Stapling System in Gastroesophageal Reflux Disease (GERD)CompletedNCT00734747Phase 3Results posted
• A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)CompletedNCT00734097Phase 4Results posted
• The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic EsophagitisCompletedNCT00728481Phase 2/3Results posted
• Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) SymptomsCompletedNCT00703534Phase 2Results posted
• Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study USCompletedNCT00660660Phase 4Results posted
• Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)CompletedNCT00658775Phase 3Results posted

← Gastroesophageal Reflux overview